Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Use advanced search instead (articles only)
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Cardiovascular Conditions
Vol. 4, Issue 1, 2016
January 28, 2016 EDT
Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain
Xavier Granero Xiberta
,
Antonio Murcia
,
José Ricardo Troncoso Durán
,
Claudio Gómez Zubeldia
,
Aleix Llorac Moix
,
Ruth Graefenhain De Codes
,
Maria Giovana Ferrario
,
Luis Lizán
,
budget impact
enoxaparin
rivaroxaban
major orthopedic surgery
total knee replacement
total hip replacement
antithrombotic prophylaxis
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9824
Photo by
Piron Guillaume
on
Unsplash
JHEOR
1.
Granero Xiberta X, Murcia A, Troncoso Durán JR, et al. Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain.
JHEOR
. 2016;4(1):35-46.
doi:10.36469/9824
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats